Skip to main navigation Skip to search Skip to main content

Randomized trial of Gilteritinib vs midostauring in FLT3 mutated acute myeloid leukemia

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date01/28/22 → 01/27/24

Funding

  • PrECOG Limited Liability Corporation: $26,800.00